Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$119,943,010
+$58,314,741 QoQ
Shares Held
100,000
+49.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#350
of 4,632 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$119,943,010
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. LLY ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
100,000 | $119,943,010 | |
| 2 | AMGN |
Amgen Inc
|
281,000 | $101,755,720 | |
| 3 | ABBV |
AbbVie Inc.
|
402,440 | $101,270,001 | |
| 4 | NVO |
Novo Nordisk A S
|
730,000 | $34,996,200 | |
| 5 | BIIB |
Biogen Inc.
|
90,000 | $19,445,400 | |
| 6 | PFE |
Pfizer Inc
|
435,000 | $10,474,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,540 | $3,257,834 | |
| 8 | GRFS |
Grifols SA
|
435,361 | $3,082,355 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,943,010 | 100,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $119,943,010 | 100,000 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $27,593,100 | 30,000 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $61,628,269 | 67,004 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $26,995,963 | 25,120 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $42,987,204 | 40,000 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $72,485,000 | 95,000 | Call | Sole | 2025-12-15 | |
| 2025-09-30 | $33,965,708 | 44,516 | Shares | Sole | 2025-12-15 | |
| 2025-09-30 | $91,560,000 | 120,000 | Put | Sole | 2025-12-15 | |
| 2025-06-30 | $2,182,684 | 2,800 | Call | Sole | 2025-08-18 | |
| 2025-06-30 | $191,945,230 | 246,232 | Shares | Sole | 2025-08-18 | |
| 2025-06-30 | $175,316,297 | 224,900 | Put | Sole | 2025-08-18 | |
| 2025-03-31 | $322,999,360 | 391,083 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $167,742,321 | 203,100 | Put | Sole | 2025-05-14 | |
| 2024-12-31 | $206,455,188 | 267,429 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $247,040,000 | 320,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $30,880,000 | 40,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $70,875,200 | 80,000 | Shares | Sole | 2024-11-13 | |
| 2024-09-30 | $70,875,200 | 80,000 | Put | Sole | 2024-11-13 | |
| 2024-06-30 | $353,098,200 | 390,000 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $353,098,200 | 390,000 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $15,559,200 | 20,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $16,064,692 | 27,559 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,742,600 | 20,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,958,990 | 25,500 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $73,168,000 | 200,000 | Shares | Sole | 2023-02-14 | |
| 2021-03-31 | $934,100 | 5,000 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||